Boyds is delighted to announce the appointment of Dr Katherine Bowen to Vice President of Regulatory Affairs.
Katherine joined Boyds in 2022 as Senior Director of Regulatory Affairs. Since then, she has led client projects, providing strategic and operational regulatory advice to facilitate regulatory input, incentives, and early market access.
With over 16 years’ experience in regulatory affairs spanning both mid-sized to large pharma and consultancies, Katherine has worked across a broad range of therapeutic areas from early phase to regulatory approval with a focus on the US and EU.
As well as supporting the Regulatory Affairs team at Boyds, Katherine has specialist expertise in oncology, clinical development, and marketing authorisation applications. In 2023, Katherine won The Organisation for Professionals in Regulatory Affairs’ (TOPRA) Inspiration Award, recognising her achievements as a mentor and leader.
Katherine’s appointment also means she will join Boyds’ Executive Leadership Team and will play an instrumental role in strategic business decision-making.
Commenting on Katherine’s promotion, Professor Alan Boyd, President and CEO of Boyds, said: “We are thrilled to announce Katherine’s well-deserved promotion. She is well-respected in her field and has made a profound difference to the company in such a short space of time, providing specialist, strategic regulatory advice to our client base whilst supporting our expert, award-winning Regulatory Affairs team. As Vice President of Regulatory Affairs, Katherine will head up our Regulatory Affairs offering, supporting biotechs and pharma companies across the globe with her extensive knowledge and pragmatic approach. We also look forward to her being part of our Executive Leadership Team.”
Katherine added: “I am delighted to be taking on the role of VP, Regulatory Affairs at Boyds and am incredibly excited to lead our talented, innovative and award-winning Regulatory Affairs Team to further support the biotech and pharma industry. I thank Alan and the Executive Leadership Team for this amazing opportunity and look forward to further contributing to the success of the organisation.”
